December 2015 |
|
Wyden-Grassley Sovaldi Investigation Finds Revenue-Driven Pricing Strategy Behind $84,000 Hepatitis Drug
|
November 2015 |
|
Wyden Statement on Pfizer-Allergan Merger
|
|
Wyden Statement Regarding New Treasury Guidance on Inversions
|
|
Wyden Requests Update on 1332 Waiver Implementation from HHS
|
|
Wyden to DOJ, FTC: Reported Beer Merger Must Not Crowd Out Craft Brewers, Raise Beer Prices and Hurt Consumers
|
|
Wyden Statement on Release of Trans-Pacific Partnership Text
|
October 2015 |
|
Wyden Statement on CMS Decision on Biosimilar Drug Payment Rule
|
|
Wyden Statement on Increased Congressional Staff Access to Trade Documents
|
|
Wyden Statement on Bipartisan Budget Agreement
|
|
Wyden Cheers Proposed Treasury Rules Enshrining Marriage Equality in Tax Law
|
|
Wyden Hails Action by Trade Agencies to Track E-Cigarette Imports
|
|
Wyden Statement on Substantial Increase in Medicare Costs Due to No Social Security COLA
|
|
Wyden Applauds Senate Confirmation of Tom Reeder to be PBGC Director
|
|
Wyden Praises Enforcement of Laws Against Illegal Timber Smuggling
|
|
Wyden To Secretary Lew: Volkswagen’s Clean Energy Tax Breaks Should Be Recovered, but Car Buyers Should Not Be Penalized
|